OPSEU Pension Plan Trust Fund’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-8,500
Closed -$2.51M – 275
2022
Q3
$2.51M Buy
8,500
+62
+0.7% +$17.8K 0.66% 21
2022
Q2
$2.36M Buy
8,438
+3,119
+59% +$835K 0.59% 30
2022
Q1
$1.39M Buy
5,319
+185
+4% +$43.9K 0.33% 135
2021
Q4
$1.14M Buy
5,134
+20
+0.4% +$3.89K 0.26% 169
2021
Q3
$921K Sell
5,114
-130
-2% -$25.4K 0.23% 182
2021
Q2
$1.06M Buy
+5,244
New +$1.1M 0.27% 171

Other funds holding VRTX

OPSEU Pension Plan Trust Fund's VRTX Position: Q4 2022 in Review

OPSEU Pension Plan Trust Fund sold out of Vertex Pharmaceuticals (VRTX) in Q4 2022, closing a stake of 8,500 shares — an estimated $2.51M sold.

OPSEU Pension Plan Trust Fund first reported a position in VRTX in Q2 2021 and held it in 6 quarters. The position peaked at $2.51M in Q3 2022. 1,222 funds tracked by Wall St. Rank hold VRTX as of Q4 2022.

  • OPSEU Pension Plan Trust Fund reported no remaining Vertex Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • OPSEU Pension Plan Trust Fund sold 8,500 Vertex Pharmaceuticals shares in Q4 2022, an estimated $2.51M.
  • OPSEU Pension Plan Trust Fund first reported a position in Vertex Pharmaceuticals in Q2 2021 and held it in 6 quarters.
  • OPSEU Pension Plan Trust Fund's Vertex Pharmaceuticals position peaked at $2.51M in Q3 2022.
  • 1,222 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2022.

Based on OPSEU Pension Plan Trust Fund's 13F filing for Q4 2022, filed 9 Feb 2023.